Showing results (311-320 of 387) with videos related to
Sort By:
Pageof 39
JCO Clinical Cancer Informatics|January 18, 2019
Structured Approach for Evaluating Strategies for Cancer Ascertainment Using Large-Scale Electronic Health Record DataAshley Earles, Lin Liu, Ranier Bustamante, et al.Journal of Hepatology|March 5, 2013
Antiviral activity of boceprevir monotherapy in treatment-naive subjects with chronic hepatitis C genotype 2/3Marcelo O Silva, Michelle Treitel, Donald J Graham, et al.Vaccines|July 2, 2021
Global Trends and Correlates of COVID-19 Vaccination Hesitancy: Findings from the iCARE StudyJovana Stojanovic, Vincent G Boucher, Myriam Gagne, et al.Cancer|November 5, 2015
Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: A randomized controlled trial in a safety-net health systemAmit G Singal, Samir Gupta, Jasmin A Tiro, et al.BMC Pediatrics|February 27, 2021
Study protocol: baby-OSCAR trial: Outcome after Selective early treatment for Closure of patent ductus ARteriosus in preterm babies, a multicentre, masked, randomised placebo-controlled parallel group trialSamir Gupta, Edmund Juszczak, Pollyanna Hardy, et al.Preventive Medicine Reports|July 31, 2019
Colorectal cancer screening among Hispanics/Latinos in the HCHS/SOL sociocultural ancillary studySheila F Castañeda, Linda C Gallo, Jesse Nodora, et al.JCO Clinical Cancer Informatics|March 7, 2020
OncoMX: A Knowledgebase for Exploring Cancer Biomarkers in the Context of Related Cancer and Healthy DataHayley M Dingerdissen, Frederic Bastian, K Vijay-Shanker, et al.Preventing Chronic Disease|December 7, 2023
Mail-Based Self-Sampling to Complete Colorectal Cancer Screening: Accelerating Colorectal Cancer Screening and Follow-up Through Implementation ScienceSamir Gupta, Autumn Barnes, Alison T Brenner, et al.Cancer|May 25, 2024
A pragmatic randomized trial of mailed fecal immunochemical testing to increase colorectal cancer screening among low-income and minoritized populationsMaría Elena Martínez, Scott Roesch, Valesca Largaespada, et al.Hepatology (Baltimore, Md.)|October 27, 2005
Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: efficacy, safety, and pharmacokineticsRegino P González-Peralta, Deirdre A Kelly, Barbara Haber, et al.Pageof 39